Bharat Biotech completes recruitment of 13,000 volunteers for Phase III trials of Covaxin
Updated : December 22, 2020 02:40 PM IST
According to the company, the vaccine is developed and manufactured at Bharat Biotech’s BSL-3, biocontainment facility.
The company has successfully recruited 13,000 volunteers for the Phase III clinical trials of the vaccine.
The target is to have 26,000 participants.